p53 alterations in breast cancer of the Parsi ethnic group

被引:0
|
作者
Abbas, A [1 ]
Kukreti, R [1 ]
Naik, S [1 ]
Therwath, A [1 ]
机构
[1] UNIV PARIS 07,MOL ONCOL LAB,F-75005 PARIS,FRANCE
关键词
breast cancer; SSCP; p53; mutations;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mutations in p53 are the most common genetic abnormality yet found in human cancers. p53 mutations vary among tumor types, ranging from 0-60% in major cancers. The frequency of p53 mutations in breast cancer averages around 25%. The incidence rate and the type of mutations at specific codons seem to be influenced by geographical location as well as racial and ethnic specificities. Women of the Parsi ethnic group living mostly in defined geographical areas around metropolitan Bombay are reported to have a markedly high incidence of breast cancer. In the present work, the p53 gene alterations in the Parsis were investigated using SSCP analysis. The results confirm an earlier observation that over 60% of the Parsi breast tumors harbour p53 alterations. This figure is higher than that observed in other communities. The relevance of the finding in the light of the high breast cancer incidence in the Parsis is discussed.
引用
收藏
页码:401 / 404
页数:4
相关论文
共 50 条
  • [1] P53 AND RB ALTERATIONS IN OPERABLE BREAST-CANCER
    NOGUCHI, M
    KITAGAWA, H
    MICHAEL, T
    KINOSHITA, K
    EARASHI, M
    MIYAZAKI, I
    MIZUKAMI, W
    ONCOLOGY REPORTS, 1994, 1 (01) : 133 - 138
  • [2] P53 ALTERATIONS IN ALL STAGES OF BREAST-CANCER
    DAVIDOFF, AM
    KERNS, BJM
    PENCE, JC
    MARKS, JR
    IGLEHART, JD
    JOURNAL OF SURGICAL ONCOLOGY, 1991, 48 (04) : 260 - 267
  • [3] MAINTENANCE OF P53 ALTERATIONS THROUGHOUT BREAST-CANCER PROGRESSION
    DAVIDOFF, AM
    KERNS, BJM
    IGLEHART, JD
    MARKS, JR
    CANCER RESEARCH, 1991, 51 (10) : 2605 - 2610
  • [4] p53 and breast cancer
    Ziyaie, D
    Hupp, TR
    Thompson, AM
    BREAST, 2000, 9 (05): : 239 - 246
  • [5] Racial comparison of p53 alterations in breast cancer: Difference in prognostic value
    Shiao, YH
    Chen, VW
    Wu, XC
    Scheer, WD
    Lehmann, HP
    Malcom, GT
    Boudreau, DA
    Ruiz, B
    Correa, P
    IN VIVO, 1996, 10 (02): : 169 - 173
  • [6] The role of p53 alterations in ovarian cancer
    Kounelis, S
    Kanbour-Shakir, A
    Papadakis, H
    Theocharis, SE
    Bakker, A
    Swalsky, PA
    Finkelstein, SD
    LABORATORY INVESTIGATION, 1999, 79 (01) : 119A - 119A
  • [7] Is p53 a breast cancer gene?
    Polyak, K
    CANCER BIOLOGY & THERAPY, 2002, 1 (01) : 37 - 38
  • [8] P53 and breast cancer, an update
    Lacroix, Marc
    Toillon, Robert-Alain
    Leclercq, Guy
    ENDOCRINE-RELATED CANCER, 2006, 13 (02) : 293 - 325
  • [9] The p53 pathway in breast cancer
    Milena Gasco
    Shukri Shami
    Tim Crook
    Breast Cancer Research, 4
  • [10] P53 AND BREAST CANCER SUBTYPES
    Bertheau, P.
    Lehmann-Che, J.
    Varna, M.
    Dumay, A.
    Poirot, B.
    Turpin, E.
    Plassa, L.
    De Cremoux, P.
    Janin, A.
    Giacchetti, S.
    Espie, M.
    De The, H.
    BREAST, 2013, 22 : S4 - S4